Back

Brca1 heterozygosity leads to hepatic steatosis in male and female mice despite sexually dimorphic effects on systemic metabolism

Palikhe, S.; Qiao, L.; Kutz, C.; Liang, X.; Dhorajiya, P.; Koestler, D. C.; Bhardwaj, P.; McCoin, C. S.; Peterson, O.; Tse, H. M.; Thyfault, J. P.; Brown, K. A.

2026-02-26 physiology
10.64898/2026.02.25.708005 bioRxiv
Show abstract

Carrying a germline mutation in BRCA1 is associated with an increased risk of several cancers, including breast and ovarian. Our recent work has demonstrated that obesity is associated with elevated levels of DNA damage in breast glands in this high-risk population. BRCA1 is a canonical tumor suppressor gene primarily recognized for its role in DNA damage repair, yet emerging evidence suggests broader functions in metabolic regulation. To determine whether heterozygous loss of Brca1, as seen in individuals who carry a germline mutation, modifies susceptibility to diet-induced metabolic dysfunction in a sex-dependent manner, we subjected wild-type (WT) and Brca1+/- mice of both sexes to a high-fat diet (HFD) and performed longitudinal metabolic phenotyping. Female Brca1+/- mice exhibited pronounced obesity, increased adiposity, hyperinsulinemia, and impaired glucose tolerance. In contrast, male Brca1+/- mice showed modest resistance to HFD-induced weight gain and displayed improved glucose tolerance compared to WT controls. Notably, Brca1 heterozygosity led to more severe hepatic steatosis with HFD, indicating a shared susceptibility to liver lipid accumulation despite divergent systemic outcomes. In females, steatosis was associated with reduced mitochondrial respiratory complex IV activity and transcriptional remodeling that favored lipid storage. Treatment with the dual GLP1/GIP receptor agonist tirzepatide ameliorated systemic metabolic dysfunction and hepatic steatosis in HFD-fed female Brca1+/- mice. These findings identify Brca1 heterozygosity as a modifier of metabolic disease risk, expanding BRCA1 biology beyond tumor suppression. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=87 SRC="FIGDIR/small/708005v1_ufig1.gif" ALT="Figure 1"> View larger version (19K): org.highwire.dtl.DTLVardef@17f9592org.highwire.dtl.DTLVardef@134c2c2org.highwire.dtl.DTLVardef@de69d8org.highwire.dtl.DTLVardef@1f6f1af_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Molecular Metabolism
105 papers in training set
Top 0.1%
39.8%
2
Cell Reports
1338 papers in training set
Top 0.6%
14.9%
50% of probability mass above
3
eLife
5422 papers in training set
Top 13%
6.4%
4
Diabetes
53 papers in training set
Top 0.1%
6.4%
5
Nature Communications
4913 papers in training set
Top 37%
4.0%
6
Journal of Clinical Investigation
164 papers in training set
Top 2%
2.6%
7
Journal of Lipid Research
35 papers in training set
Top 0.2%
2.1%
8
Genes & Development
90 papers in training set
Top 0.3%
1.9%
9
JCI Insight
241 papers in training set
Top 5%
1.2%
10
Cell Reports Medicine
140 papers in training set
Top 6%
1.0%
11
American Journal of Physiology-Endocrinology and Metabolism
34 papers in training set
Top 0.3%
0.9%
12
The Journal of Clinical Endocrinology & Metabolism
35 papers in training set
Top 1%
0.9%
13
Nucleic Acids Research
1128 papers in training set
Top 16%
0.8%
14
Nature
575 papers in training set
Top 14%
0.8%
15
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 44%
0.8%
16
PLOS Genetics
756 papers in training set
Top 16%
0.7%
17
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.7%
0.7%
18
Nature Metabolism
56 papers in training set
Top 3%
0.7%
19
Physiological Genomics
15 papers in training set
Top 0.6%
0.5%
20
Science Advances
1098 papers in training set
Top 34%
0.5%
21
Scientific Reports
3102 papers in training set
Top 80%
0.5%
22
EMBO reports
136 papers in training set
Top 8%
0.5%
23
PLOS ONE
4510 papers in training set
Top 73%
0.5%